Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Epilepsy treatment drugs industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug class trends
2.1.4 Type trends
2.1.5 Route of administration trends
2.1.6 Age group trends
2.1.7 Seizure type trends
2.1.8 Distribution channel trends
Chapter 3 Epilepsy Treatment Drugs Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of epilepsy
3.2.1.2 Increasing investments in R&D activities
3.2.1.3 Increasing demand for novel treatment for epilepsy
3.2.1.4 Growing awareness and early diagnosis
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects associated with the antiepileptic drugs
3.2.2.2 Patent expiration
3.3 Growth potential analysis
3.3.1 By drug class
3.3.2 By type
3.3.3 By route of administration
3.3.4 By age group
3.3.5 By seizure type
3.3.6 By distribution channel
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023
Chapter 5 Epilepsy Treatment Drugs Market Estimates and Forecast, By Drug Class, 2018-2032 (USD Million)
5.1 Key trends, by drug class
5.2 First-generation
5.3 Second-generation
5.4 Third generation
Chapter 6 Epilepsy Treatment Drugs Market Estimates and Forecast, By Type, 2018-2032 (USD Million)
6.1 Key trends, by type
6.2 Branded
6.3 Generics
Chapter 7 Epilepsy Treatment Drugs Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)
7.1 Key trends, by route of administration
7.2 Oral
7.3 Nasal
7.4 Injectable
7.5 Rectal
Chapter 8 Epilepsy Treatment Drugs Market Estimates and Forecast, By Age Group, 2018-2032 (USD Million)
8.1 Key trends, by age group
8.2 Pediatric
8.3 Adult
Chapter 9 Epilepsy Treatment Drugs Market Estimates and Forecast, By Seizure Type, 2018-2032 (USD Million)
9.1 Key trends, by seizure type
9.2 Focal seizure
9.3 Generalized seizure
9.4 Combined seizure
Chapter 10 Epilepsy Treatment Drugs Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)
10.1 Key trends, by distribution channel
10.2 Hospital pharmacies
10.3 Retail pharmacies
10.4 Online pharmacies
Chapter 11 Epilepsy Treatment Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East & Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East & Africa
Chapter 12 Company Profiles
12.1 UCB Pharma S.A.
12.2 GlaxoSmithKline Plc
12.3 Sanofi
12.4 SK Biopharmaceuticals
12.5 Eisai Co., Ltd.
12.6 Novartis AG
12.7 Novel Laboratories Inc.
12.8 Pfizer Inc.
12.9 Neurelis, Inc.
12.10 Bausch Health Companies Inc.
12.11 Dr. Reddy's Laboratories
12.12 Sumitomo Pharma
12.13 Jazz Pharmaceuticals, Inc.
12.14 Sun Pharmaceutical Industries Ltd.
